BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 34720027)

  • 1. Immune thrombocytopenia.
    Bussel J; Cooper N; Boccia R; Zaja F; Newland A
    Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches for the diagnosis and management of immune thrombocytopenia.
    Gafter-Gvili A
    Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging treatments for immune thrombocytopenia.
    Dou X; Yang R
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.
    Britto J; Holbrook A; Sun H; Cserti-Gazdewich C; Prokopchuk-Gauk O; Hsia C; Khamisa K; Yenson PR; Sholzberg M; Olney HJ; Shivakumar S; Jones D; Merkeley H; Costello J; Jamula E; Arnold DM
    Clin Invest Med; 2024 Mar; 47(1):13-22. PubMed ID: 38546381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of refractory primary immune thrombocytopenia.
    Moulis G; Garabet L
    Br J Haematol; 2023 Oct; 203(1):112-118. PubMed ID: 38019080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
    Vianelli N; Auteri G; Buccisano F; Carrai V; Baldacci E; Clissa C; Bartoletti D; Giuffrida G; Magro D; Rivolti E; Esposito D; Podda GM; Palandri F
    Ann Hematol; 2022 May; 101(5):963-978. PubMed ID: 35201417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
    Kikuchi K; Miyakawa Y; Ikeda S; Sato Y; Takebayashi T
    BMC Health Serv Res; 2015 Jan; 15():2. PubMed ID: 25609557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
    Lv Y; Shi H; Liu H; Zhou L
    Front Immunol; 2022; 13():953716. PubMed ID: 36003388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.
    Lozano ML; Godeau B; Grainger J; Matzdorff A; Rodeghiero F; Hippenmeyer J; Kuter DJ
    Expert Rev Hematol; 2020 Dec; 13(12):1319-1332. PubMed ID: 33249935
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
    Journeycake JM
    Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated guidelines for immune thrombocytopenic purpura: Expanded management options.
    DeSouza S; Angelini D
    Cleve Clin J Med; 2021 Dec; 88(12):664-668. PubMed ID: 34857604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ITP].
    Yokoyama K
    Rinsho Ketsueki; 2021; 62(8):1229-1235. PubMed ID: 34497211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
    Tamary H; Roganovic J; Chitlur M; Nugent DJ
    Ann Hematol; 2010 Jul; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists.
    Lu KH; George JN; Vesely SK; Terrell DR
    Am J Med Sci; 2014 Mar; 347(3):190-4. PubMed ID: 23462246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Thrombocytopenia in Children: Consensus and Controversies.
    Singh G; Bansal D; Wright NAM
    Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.
    Janssens A; Selleslag D; Depaus J; Beguin Y; Lambert C
    Acta Clin Belg; 2022 Apr; 77(2):470-483. PubMed ID: 33635747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of immune thrombocytopenia.
    Červinek L
    Vnitr Lek; 2018; 64(5):526-529. PubMed ID: 30193522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.